195 results about "Arteriosclerosis" patented technology

The invention relates to the technical field of health status assessment, in particular to a cardiovascular disease layered early warning system, which is characterized in that blood vessel compliance and pulse wave velocity are extracted, arterial dilation capacity is measured, blood vessel elasticity is calculated, blood perfusion distribution is detected, and abnormal vasoconstriction is classified on the basis of a hemodynamic state and a heart electrical activity state; in combination with the thickness of the blood vessel wall and the blood vessel stenosis rate, the plaque deposition condition is analyzed, the arteriosclerosis score is calculated, the thrombosis tendency is detected, the local blood flow blocking degree is quantified, the isolation forest algorithm is adopted, the blood flow dynamic change is calculated, the heart rhythm abnormality is analyzed, the acute vascular occlusion probability is measured, and the sudden heart rhythm abnormality risk is evaluated. And based on a gradient boosting tree algorithm, screening high-risk cases, matching medical intervention measures, setting a risk buffer mechanism, adjusting an individual health management strategy, and optimizing a cardiovascular risk hierarchical early warning system.

The invention relates to the field of computer medical engineering, and discloses a blood pressure continuous measurement abnormity early warning method and system based on AI data analysis, and the method comprises the steps: collecting a pulse wave signal, triaxial accelerometer data, an ambient light intensity signal and a skin conductance signal through a sensor on a preset wearable device; generating multi-scale physiological features; systolic pressure and diastolic pressure are calculated, and blood vessel stiffness is calculated; calculating the main arteriosclerosis risk level; when the main arteriosclerosis risk level is higher than a preset risk level, a user is prompted through the wearable device. According to the invention, the pulse wave, the triaxial accelerometer, the ambient light intensity and the skin conductance signal are synchronously acquired and analyzed to obtain the systolic pressure, the diastolic pressure dynamic trend and the blood vessel stiffness, and the main arteriosclerosis risk level can be accurately quantified. In addition, a'physiological parameter-angiosclerosis-risk decision 'closed-loop management mechanism is established, and automatic and active health management of the user is realized.

The invention discloses a pulse wave monitoring method and system based on telemetry photoplethysmography, and the method comprises the steps: collecting a video file of a carotid artery region based on telemetry photoplethysmography, obtaining a plurality of frames of images in the video file, and determining a gray level image corresponding to each frame of image; acquiring two regions of interest in the grayscale image, and extracting two original pulse wave signals from the two regions of interest; performing zero phase shift filtering and interpolation processing on the two original pulse wave signals to obtain two processed pulse wave signals; performing normalization processing and cross-correlation calculation on the two processed pulse wave signals to obtain a time difference between the two pulse wave signals; according to the time difference of the two pulse wave signals and the distance between the two interested areas, the pulse wave speed is calculated, and the arteriosclerosis degree is evaluated based on the pulse wave speed. The carotid artery pulse wave is monitored in a non-invasive mode, arteriosclerosis is evaluated, and cardiovascular health is guaranteed.

The invention discloses a non-invasive wearable vascular arteriosclerosis assessment system and method based on multi-mode pulse wave signal fusion, and belongs to the field of vascular function assessment. The system comprises a distributed acquisition front end, a butterfly-shaped flexible substrate, an integrated double-accelerometer, a four-wavelength LED (530nm / 660nm superficial blood vessel measurement), a 810nm / 940nm deep artery measurement device, a double-photodiode, a double-impedance electrode and a pressure sensor. The central integrated control end processes a multi-mode signal and realizes pressure-LED current closed-loop control; the upper computer terminal extracts the multi-modal pulse wave time difference of the limbs and the neck, the local and regional pulse wave conduction velocity and the blood oxygen hemoglobin change parameters induced by the standardized posture, the dimension is reduced to 30 through principal component analysis, then the parameters are input into the random forest regression model, and the vascular elasticity index is output. Signal stability is improved through flexible fitting, single-source limitation is solved through multi-modal fusion, signal quality is guaranteed through closed-loop control, sensitivity is enhanced through dynamic physiological excitation, and accuracy and universality of arteriosclerosis assessment are improved.

The invention discloses a preparation method and processing equipment of herbal composite granules, and relates to the technical field of composite granules. Comprising the following components in parts by weight: 15-20 parts of soybean phospholipid, 10-15 parts of glutamine, 10-15 parts of L-arginine, 5-10 parts of a ginseng extract, 5-10 parts of phytosterol, 5-10 parts of xylooligosaccharide, 5-10 parts of inositol, 5-10 parts of a hawthorn extract, 5-10 parts of a blueberry extract, 5-10 parts of an acerola cherry extract, 0-5 parts of yeast beta glucan, 0-5 parts of a sea-buckthorn extract, 0-5 parts of a tartary buckwheat extract, 0-5 parts of haematococcus pluvialis and the like. The composition is innovative and breakthrough in successful application in the aspects of heart and cerebral vessels and anti-aging, and can regulate intestines, protect liver, reduce blood pressure and regulate blood fat; thrombus is melted, the vascular endothelial function is improved, and arteriosclerosis is prevented; meanwhile, the effects of resisting oxidation, resisting inflammation, resisting aging and enhancing immunity can also be achieved.

The invention provides an artery plaque intracavitary directional rotary cutting device and a using method thereof, and belongs to the technical field of medical instruments. The arterial plaque intracavitary directional rotary cutting device comprises a tool bit protection sleeve, a medicine storage part, a windmill type rotary cutting tool bit, a hollow spiral-line-shaped long-strip net bag structure recycling net, a metal supporting net, a guide pipe and a control unit. On the basis of having the advantages of a plaque excision device in the prior art, the artery plaque intracavity directional rotary cutting device further has the following advantages that (1) the rotary cutting position is accurate; (2) the medicine is suitable for treating patients with femoral popliteal lesion and below-knee arteriosclerosis obliterans; (3) the operation cost and the operation risk are low; (4) the stimulation and trauma to a patient are small in an operation; (5) the rotary cutting depth is long; (6) the cut plaques and chippings can be prevented from falling off; (7) the restenosis progress of blood vessels can be delayed, and inflammatory response and immune response caused by operations can be relieved; and (8) the device is easy to clean after operation.

The present invention is a method for measuring arterial elasticity under a cuff pressure-maintaining state, comprising step 1: adjusting a linear deflation valve to keep the air pressure of the cuff stable; step 2: collecting pulse waves under the cuff pressure-maintaining state; step 3: using FIR high-pass and low-pass filters to filter the signal, with passbands of 0.05HZ and 30HZ respectively; step 4: screening the obtained pulse wave signal, and eliminating the waveform under the state of body misoperation according to the width and amplitude of the pulse wave; step 5: using a linear function to eliminate the baseline; step 6: normalizing a single pulse; step 7: finding the starting point of the reflected wave; step 8: calculating the intensity of the reflected wave; step 9: screening the calculation results of multiple pulse waves. The present invention reduces the baseline rebound in the initial stage of pressure maintenance by adjusting the linear deflation valve, so that the useful pulse wave signal is more complete, and the use of a single airbag not only solves the problem of inconvenient measurement, but also can better reflect the degree of arteriosclerosis of the human body by measuring the elastic coefficient of the artery.

The invention discloses an arteriosclerosis risk prediction method and device based on machine learning, and belongs to the technical field of machine learning, and the method comprises the steps: obtaining electronic medical record data of a target object, and carrying out the standardization processing; inputting the standardized electronic medical record data into a machine learning model based on a LightGBM algorithm to identify high-risk individuals of arteriosclerosis; the influence of each feature on the arteriosclerosis risk prediction result is quantified by combining the contribution values of the input features, and targeted health management suggestions are provided for patients. The arteriosclerosis risk prediction model constructed by learning a large amount of clinical data not only can improve the accuracy of arteriosclerosis risk prediction, but also can reveal the complex relationship between risk factors which are difficult to find by a traditional statistical method, so that the design and implementation of a personalized health management scheme are realized. Therefore, a more scientific basis is provided for preventing and treating arteriosclerosis.

An advanced cardiovascular health monitoring system utilizes an optical pulse wave velocity detection device in combination with a system for analyzing data waveforms structures in combination with personalized patient data integration to determine specific physiological parameters for monitoring and assessing specific health conditions. Using acceleration pulse waves, vascular health is calculated by the ratio of peak to the second derivative of blood volume pulse wave, which can detect various health indices such as vascular age, vascular health index, and arteriosclerosis. The device collects separate pulse points within a time interval. It connects them into a line to form the PPG Image, which is then analyzed through data filtering and fitting methods. The periodic cycle acquisition method excludes abnormal cycle data and ensures correct data acquisition. Artificial Intelligence and data analytics are aiding the software to improve and optimize underlying data ranges continuously; the algorithms are summarized in figures. The invention may be used as part of non-invasive screening testing.

The invention discloses an arteriosclerosis detection method, device and system and an arteriosclerosis detector, and relates to the technical field of medical instruments.The method comprises the steps that after carotid artery pulse waveforms and femoral artery pulse waveforms are subjected to preprocessing and differential processing, division is conducted according to heartbeat cycles; acquiring a carotid artery signal maximum value and a femoral artery signal maximum value in each heartbeat cycle; determining conduction time in each heartbeat cycle according to the carotid artery signal maximum value and the femoral artery signal maximum value in each heartbeat cycle; according to the distance between the carotid artery measuring point and the femoral artery measuring point and the conduction time in each heartbeat cycle, the conduction speed of the pulse wave of the tested person in the arterial system in each heartbeat cycle is determined; determining an average conduction velocity according to the conduction velocity of the pulse wave of the testee in the arterial system in each heartbeat cycle; and determining the arteriosclerosis degree according to the average conduction velocity. The technical problem of low arteriosclerosis measurement precision in the prior art is solved.

The invention relates to a collateral-dredging thrombus-removing traditional Chinese medicine composition for preventing and treating stroke, vascular thrombus, arteriosclerosis, coronary heart disease or waist and leg pain. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 12-65 parts of cooked rhubarb, 10-72 parts of salvia miltiorrhiza, 12-65 parts of cortex moutan, 6-57 parts of rhizoma zingiberis, 8-50 parts of pseudo-ginseng, 15-45 parts of obscured homalomena rhizome, 10-68 parts of leech, 7-76 parts of earthworm, 15-70 parts of ligusticum wallichii, 6-52 parts of Tibetan capillary artemisia, 7-49 parts of cape jasmine, 3-25 parts of borneol, 6-75 parts of angelica sinensis, 12-65 parts of ginseng, 7-53 parts of pogostemon cablin and 10-77 parts of radix curcumae. The medicine has the effects of promoting blood circulation, removing blood stasis, dredging collaterals and removing thrombus. The traditional Chinese medicine composition can be used for preparing medicines for treating cerebral apoplexy, coronary heart disease, arteriosclerosis and static artery thrombosis diseases, or medicines for soothing channels, activating collaterals and promoting blood circulation to remove blood stasis, which are related to waist and leg pain diseases. The invention provides a prevention and treatment effective solution for people with stroke, vascular thrombosis, arteriosclerosis, coronary heart disease or waist and leg pain.

According to the arteriosclerosis detection method and device, the upper arm blood pressure is obtained based on the heart and ankle vascular index CAVI; systolic pressure Ps and diastolic pressure Pd are obtained; calculating to obtain a pulse pressure difference delta P, wherein the pulse pressure difference delta P = systolic pressure Ps-diastolic pressure Pd; measuring to obtain the distance Lca from the heart aortic valve to the ankle; measuring to obtain the time difference Tca of the pulse wave propagating from the heart to the ankle; a heart and ankle vascular index CAVI is obtained through calculation according to the following formula; # imgabs0 # is used for measuring and obtaining a pulse wave starting point time point TA1 of the ankle; measuring a pulse starting point TA2 of brachial artery pulse waves, and calculating TA1 to TA2 to obtain a time difference Tba; measuring to obtain a heart sound signal of cardiac pulsation, and obtaining a time difference T2 between a second heart sound and a first incision of the brachial artery; the time difference Tca is equal to the sum of the time difference Tba and the time difference T2. At least three blood pressure measuring devices and at least three electrocardio detection electrodes are arranged; the heart sound detection module is in electric signal connection with the heart sound detection sensor through a signal line; the heart sound detection sensor is used for being placed at the heart position of a detected person to obtain heart sound signals.

The invention provides a construction method of a lower limb arteriosclerosis obliterans model, and belongs to the field of model construction. The problem of low construction efficiency of the lower limb arteriosclerosis obliterans model is solved; the method specifically comprises the following steps: S1, acquiring pathological data of a patient; s2, acquiring historical medical records of a target hospital, performing primary processing on the historical medical records, determining main observation indexes of a patient, and constructing an equation F (1); s3, carrying out secondary analysis on the historical medical record, and constructing an equation F (2); according to the equation F (1) and the equation F (2), ankle systolic pressure changes and brachial artery systolic pressure changes of the patient are analyzed; s4, extracting a lesion picture in the medical examination report of the patient, and constructing a three-dimensional model of the lower limbs of the patient; summarizing and feeding back the pre-diagnosis reports; according to the method, the mathematical model and the three-dimensional model of the lower limb arteriosclerosis obliterans are constructed by acquiring and analyzing the related information of the patient with the lower limb arteriosclerosis obliterans, and the medical efficiency of the lower limb arteriosclerosis obliterans

According to the walking simulation electrical stimulation system for the bedridden lower limb arteriosclerosis obliterans patient, after the control host receives a walking simulation electrical stimulation instruction, the multi-channel electrical stimulation generation unit is controlled to generate an electrical stimulation signal matched with the target walking simulation stimulation level, and the electrical stimulation signal is applied to the lower limbs of the patient through the multi-channel stimulation electrode; controlling pause when the target stimulation time is reached; the multi-channel myoelectricity acquisition unit acquires myoelectricity signals of the lower limbs of the patient through a multi-channel myoelectricity electrode; the control host judges that the multi-channel electromyographic electrodes are not in contact with the patient well according to the multi-channel electromyographic signals within the first set time from the beginning, gives an alarm, and obtains the multi-channel electromyographic signals within the second set time from the end of the target stimulation time after judging that the contact is good; performing preprocessing and feature extraction on the electromyographic signals of each channel within the time to obtain multi-channel features, and inputting the multi-channel features into a target neural network recognition model to recognize and obtain a lower limb arteriosclerosis obliterans recognition result of the patient.

The present invention relates to the use of an ROR inverse agonist or a pharmaceutically acceptable salt thereof for the preparation of a medicament for modulating ROR in a patient and / or for controlling autoimmune diseases and antibody-mediated rejection in a patient. The ROR-mediated diseases or autoimmune diseases include HIV, cancer, celiac disease, type 1 diabetes, Graves' disease (Graves' disease), inflammatory bowel disease, multiple sclerosis, psoriasis, rheumatoid arthritis, systemic lupus erythematosus, asthma, dermatitis, fatty liver disease, Crohn's disease (Crohn's disease), cardiovascular disease, inflammatory disease, nervous system disorders, multiple sclerosis, and the like. Acute respiratory distress syndrome and arteriosclerosis.

The invention belongs to the field of medical science, and relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating chronic coronary syndrome and fading coronary artery and carotid plaques as well as a preparation method and application of the traditional Chinese medicine composition. The formula of the composition comprises 10 to 30 g of radix astragali, 10 to 18 g of salvia chinensis, 20 to 40 g of euphorbia lunulata, 6 to 15 g of rhizoma pinelliae preparata, 6 to 15 g of ginseng, 6 to 15 g of cassia twig, 6 to 15 g of radix puerariae, 6 to 15 g of dried ginger, 5 to 15 g of rhizoma cimicifugae, 5 to 15 g of radix bupleuri, 6 to 20 g of bighead atractylodes rhizome, 5 to 15 g of pericarpium citri reticulatae, 6 to 15 g of radix scutellariae, 12 to 30 g of cynanchum glaucescens, 5 to 15 g of angelica sinensis, 5 to 15 g of radix curcumae, 10 to 30 g of salvia miltiorrhiza, and 6 to 15 g of honey-fried licorice root. The composition provided by the invention treats the origin of the aggregation by tonifying qi, eliminating the aggregation, activating yang and removing stasis, and treats the source of the aggregation by tonifying spleen, reducing phlegm, promoting blood circulation to remove blood stasis and smoothing the vein, not only has an exact curative effect on improving the clinical symptoms of the chronic coronary syndrome, but also can prevent the progression of arteriosclerosis and subside coronary artery and carotid plaques, and not only has obvious curative effect on the clinical symptoms, but also has obvious curative effect on the coronary artery and carotid artery plaques. The basic pathological change of atherosclerosis can be improved, so that the chronic coronary syndrome is treated, the pathological progress of the chronic coronary syndrome is prevented and treated, the curative effect is remarkable, and the safety problem is few.

The present disclosure provides a compound capable of exhibiting an effect similar to that of 2-Cys-peroxidase reductase (2-Cys-Prx) in vivo, and a pharmaceutical use thereof, in which the compound has an excellent pharmacological effect and reduced side effects, such as reduced cytotoxicity. The compounds and pharmaceutically acceptable salts thereof of the present disclosure are useful in the treatment or prevention of vascular diseases, particularly ischemic coronary artery diseases, arteriosclerosis, vascular restenosis or pulmonary arterial hypertension. The compounds of the present invention and pharmaceutically acceptable salts thereof are particularly useful in the treatment or prevention of pulmonary arterial hypertension. The invention also provides methods of making the compounds of the disclosure.

The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a turbidity-dissolving and lipid-lowering composition and a preparation method thereof.The composition comprises 80-130 parts of polygonum cuspidatum, 50-90 parts of fried semen cassiae, 100-140 parts of hawthorn, 50-90 parts of rhizoma alismatis, 10-60 parts of rhizoma atractylodis macrocephalae fried with bran and 50-90 parts of rhizoma wenyujin concisum. The composition disclosed by the invention has the effects of eliminating phlegm, dissolving turbidity, promoting blood circulation to remove blood stasis, invigorating stomach and promoting diuresis, can be used for treating hyperlipidemia, hyperviscosity and arteriosclerotic cardia-cerebrovascular diseases, and has a very good application prospect.

The invention belongs to the field of medicaments, and discloses a nano-medicinal preparation capable of treating diabetes and a preparation method of the nano-medicinal preparation. The preparation method comprises the following steps: carrying out hydrothermal reaction on fructose-1, 6-strontium diphosphate, vanadium pentoxide and ergothioneine to prepare strontium-vanadate organic framework nanoparticles; the strontium-vanadate organic framework nano-particles, dopamine and polylysine are blended, embedding of polydopamine is achieved under the alkaline condition, polylysine-polydopamine co-embedded organic framework nano-particles are formed, and the nano-drug preparation for treating diabetes is obtained. The nano medicinal preparation can release the vanadyl complex and the ergothioneine and improve the blood strontium concentration and the half-life period thereof, so that the blood sugar is controlled, the symptoms of diabetes mellitus are improved, and the symptoms of osteoporosis, arteriosclerosis and the like complicated by diabetes mellitus are improved.

The present disclosure relates to endoplasmic reticulum protein HYOU1-binding compounds for inhibiting endoplasmic reticulum-mitochondrial interactions and uses thereof.The features and advantages of the present disclosure may be summarized as follows:(a) The present disclosure provides a compound that can bind to the endoplasmic reticulum protein HYOU1 and inhibit endoplasmic reticulum-mitochondrial interactions increased by oxLDL (oxidized low-density lipoprotein).(b) The present disclosure provides a composition capable of preventing, ameliorating or treating autophagy disorder-related diseases, particularly arteriosclerosis or pulmonary hypertension, which contains the above-described compound as an active ingredient.(c) Since the composition of the present disclosure reduces intracellular lipids by inducing autophagy in atherosclerosis-induced tissues, it can be useful used in the amelioration or treatment of atherosclerosis.(d) Since the composition of the present disclosure reduces smooth muscle cell proliferation by inducing autophagy in smooth muscle cells in which contraction is induced by TGF-β, it can be usefully used in the amelioration or treatment of pulmonary arterial hypertension.

The invention relates to the technical field of traditional Chinese medicine compositions, and particularly discloses a composition for treating lower limb arteriosclerosis obliterans, which is technically characterized by being prepared from ten medicinal materials, namely red ginseng, astragalus membranaceus, cassia twig, morinda officinalis, cistanche deserticola, salvia miltiorrhiza, pseudo-ginseng, radix cyathulae, sargentgloryvine stem and semen brassicae according to a specific weight part ratio. Aiming at the core pathogenesis of yang deficiency and blood stasis of lower limb arteriosclerosis obliterans, the composition disclosed by the invention provides a treatment method of tonifying qi, warming yang, promoting blood circulation to remove blood stasis, removing speckles and dredging vessels, the compatibility of the whole formula is rigorous, and monarch, minister, assistant and guide are clear; moreover, the composition can be prepared into capsules or granules, is used for treating yang deficiency and blood stasis type lower limb arteriosclerosis obliterans, has an exact clinical curative effect, can remarkably improve symptoms of patients and lower limb blood flow, and is good in safety.

The invention belongs to the technical field of edible oil, and particularly relates to edible oil with a blood fat reducing effect and a preparation method of the edible oil. Comprising the following raw materials in parts by weight: 1 to 10 parts of base oil, 90 to 100 parts of 1-oleic acid-2-palmitic acid-3-linoleic acid triglyceride, 0.3 to 0.5 part of an emulsifier, 0.05 to 0.09 part of an antioxidant and 0.02 to 0.05 part of a stabilizer. The base oil is composed of the sunflower seed oil and the tea seed oil, and the base oil and the 1-oleic acid-2-palmitic acid-3-linoleic acid triglyceride are matched for use, so that the oil has a good blood fat reducing effect, and can effectively reduce cholesterol, maintain cardiovascular health and prevent arteriosclerosis. The antioxidant is composed of the vitamin E, the alpha-mangostin and the oryzanol, all the components have a synergistic effect and jointly improve the oxidation stability of the edible oil, and meanwhile, the antioxidant is matched with the stabilizer, so that the storage life of the edible oil can be effectively prolonged, and the storage stability is improved.

The present invention relates to the application field of traditional Chinese medicine technology, and discloses an application of a formula of effective ingredients of Guizhi tangnausea in treating rest pain caused by diabetes. The present invention includes the composition and corresponding proportion of the formula of effective ingredients of Guizhi tangnausea, the optimal ratio and preparation type of each ingredient of the formula of effective ingredients of Guizhi tangnausea, and the application type of the formula of effective ingredients of Guizhi tangnausea in treating rest pain caused by diabetes. Combined with the behavioral pain test of rats and the clinical trial of lower limb arteriosclerosis, it is illustrated that the formula of effective ingredients of Guizhi tangnausea has a good analgesic effect and an effect of relieving lower limb arteriosclerosis in treating rest pain caused by diabetes.

The invention provides a preparation method of a balloon coating, the preparation method is used for preparing a nifedipine coating on a balloon, and the preparation method is characterized by comprising the following steps: S1, adding nifedipine and iopromide into an organic solvent according to the mass-volume ratio of nifedipine to iopromide being 30-80 mg / ml to 25-45 mg / ml to obtain a nifedipine mixed solution; and S2, coating the nifedipine mixed solution on a preset part of the balloon, and drying to obtain the nifedipine coating coated on the balloon. The invention further provides the medicine balloon prepared by the preparation method. As the balloon body is coated with the balloon coating containing nifedipine, on one hand, excitation-contraction coupling of blood vessels can be inhibited, the blood vessels at the contact part of the balloon body can be expanded, and the vasospasm state can be quickly relieved, so that the balloon is easy to pass through, and the subsequent operation can be smoothly carried out; on the other hand, nifedipine can effectively reduce platelet aggregation and prevent thrombus and arteriosclerosis plaque formation.

The invention discloses a displacement measurement method and device, a laser emitting and receiving system and an arteriosclerosis early warning instrument, and relates to the technical field of medical instruments, and the method comprises the steps: controlling a constant current source to output current to drive an infrared laser to work; acquiring an electric signal input by the optical signal receiving module; determining a phase difference between a measurement optical signal obtained by the first laser through the silicon optical chip and a measurement optical signal reflected by the surface of the to-be-measured object according to the electric signal; and determining the displacement information of the to-be-measured object according to a first mathematical relationship between the phase difference and the displacement of the to-be-measured object. According to the scheme, displacement is measured through the laser emitting and receiving system, noninvasive and high-time-resolution measurement of vibration of the blood vessel wall can be achieved without direct contact with the skin, the limitation that in the prior art, contact with the skin is needed can be overcome, and the obtained measurement result is more accurate and efficient.

The present invention relates to exosome-derived biomarkers for diagnosing arteriosclerosis. The biomarkers of the present invention exhibit specific changes in expression associated with arteriosclerosis, particularly during the early stages of the disease, and thus are highly effective for early diagnosis and prognosis of arteriosclerosis. Particularly, the 3D arteriosclerosis model of the present invention closely mimics the arterial condition of actual patients, allowing for the combined use of the biomarkers and the model to enable early diagnosis, personalized treatment development, and precise monitoring of disease prognosis.

The invention discloses an arteriosclerosis risk prediction method, device and system and a storage medium, and the method comprises the steps: obtaining a genetic risk score, a blood glucose index and basic features of a crowd arteriosclerosis index, thereby constructing an arteriosclerosis risk prediction model; and drawing a working characteristic ROC curve of the testee and calculating an area AUC under the ROC curve to evaluate the discrimination degree of the model for predicting the arteriosclerosis risk of the testee. By adopting the technical scheme of the invention, arteriosclerosis high-risk groups of the middle-aged and elderly people can be accurately screened out, and overhigh disease burden of arteriosclerosis of the middle-aged and elderly people can be prevented and controlled. Genetic and non-genetic factors are simultaneously included to judge the possibility of suffering from arteriosclerosis of middle-aged and elderly people, so that the method has certain practical guiding significance for preventing and controlling arteriosclerosis in people with abnormal blood glucose index levels.

The present invention relates to saikosaponin C as an agent for regulating vascular aging and associated arteriosclerosis, and provides a composition for treating, preventing or ameliorating aging vascular diseases, diseases caused by vascular aging, specifically arteriosclerosis, or symptoms caused by vascular aging, comprising saikosaponin C as an active ingredient. It is expected that the composition of the present invention can be used to treat, prevent or ameliorate arteriosclerosis as a complementary agent, alternative agent or combination agent for existing arteriosclerosis treatment agents that lower LDL-C.

The invention discloses a remote ischemia adaptive hypertension treatment and risk assessment system based on artificial intelligence. The system comprises a physiological signal acquisition module, a preprocessing module, an artery function assessment module, a heart rhythm analysis module, a molecular biology assessment module, a user state association module and an assessment module. The physiological signal acquisition module is responsible for executing standard distant ischemia adaptation training and acquiring original data including systolic pressure, diastolic pressure, heart rate and pulse waveform data of upper limbs on two sides in real time in the execution process; the preprocessing module can sequentially carry out band-pass filtering, waveform segmentation and feature extraction processing on original data, then feature values extracted from single waveforms and the waveforms are combined to form a data set, and the data set is output. According to the method, arteriosclerosis can be evaluated, subclavian artery stenosis can be judged, and the nitric oxide amount can be calculated synchronously, so that fusion of multiple physiological data can be ensured in an adaptive treatment process, and meanwhile, multi-data joint evaluation is realized in combination with artificial intelligence.

The embodiment of the present application provides a method and electronic device for determining the carotid-femoral pulse wave velocity, including: obtaining a user feature and a second feature, then determining the distance between the carotid artery and the femoral artery of the user to be measured based on the user feature, and determining the pulse wave propagation time between the carotid artery and the femoral artery of the user to be measured based on the second feature, and then determining the carotid-femoral pulse wave velocity value of the user to be measured according to the distance and the pulse wave propagation time. Among them, the user feature is obtained based on the user information of the user to be measured, the second feature represents the feature associated with the pulse wave propagation time, the second feature is obtained based on the first feature and the user feature, and the first feature is obtained based on the photoelectric volumetric pulse wave PPG signal, and the PPG signal is collected from the user to be measured. In this way, the detection of arteriosclerosis is achieved, and the accuracy of the carotid-femoral pulse wave velocity value can be improved, thereby improving the accuracy of the arteriosclerosis detection result.